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Previous analyses have suggested that immunity to non-cerebral severemalaria
due to Plasmodium falciparum is acquired after only a few infections, whereas
longitudinal studies show that some children experience multiple episodes of
severe disease, suggesting that immunity may not be acquired so quickly.
We fitted a mathematical model for the acquisition and loss of immunity to
severe disease to the age distribution of severe malaria cases stratified by symp-
toms from a range of transmission settings in Tanzania, combined with data
from several African countries on the age distribution and overall incidence
of severe malaria. We found that immunity to severe disease was acquired
more gradually with exposure than previously thought. The model also
suggests that physiological changes, rather than exposure, may alter the symp-
toms of disease with increasing age, suggesting that a later age at infection
would be associated with a higher proportion of cases presentingwith cerebral
malaria regardless of exposure. This has consequences for the expected pattern
of severe disease as transmission changes. Careful monitoring of the decline in
immunity associated with reduced transmission will therefore be needed to
ensure rebound epidemics of severe and fatal malaria are avoided.1. Background
AsmallminorityofPlasmodium falciparum infections result in severemalaria, requir-
ing admission to hospital [1]. Immunity to severemalaria is known to developwith
repeat infections of P. falciparum, but the rate of acquisition of immunity is a subject
of on-going study [2]. Manifestations of severe malaria have been shown to vary
with age and transmission setting [3–9], and in response to changing transmission
[10], suggesting that both age and exposure affect the pathophysiology of the dis-
ease. Previous analysis suggested that immunity to non-cerebral severe malaria is
acquired after onlyone or two infections [11]. However, evidence from longitudinal
studies shows that some young children experience multiple episodes of severe
disease [12,13], suggesting that immunity may be acquired more gradually. Age
patterns of disease are further confounded by variation in exposure to P. falciparum
and immune responses, resulting in a high degree in variability in the number of
disease episodes among children living in the same area [1,14].
A shift in the burdenof severemalaria fromyounger to olderageswithdecreas-
ing malaria transmission intensity is also associated with changes in the dominant
manifestations of disease. In high transmission settings, severe malaria is concen-
trated among young children over the age of six months who most commonly
present with severe malarial anaemia. At intermediate and low transmission
settings, cases present in older children and adults with an increasing proportion
of cerebral malaria [4,6,9,15–17], which is associated with higher case fatality
ratios [4,18–22]. Despite this, the higher case fatality ratio is more than offset
by the much lower incidence of severe malaria in low transmission settings,
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2such that—overall—malaria-related mortality decreases with
decreasing transmission [10]. Thus, although there have been
concerns that malaria control may be accompanied by a para-
doxical increase in mortality when transitioning from very
high to intermediate levels of transmission [3,23–28], inpractice,
this has not been observed in two areas where there have been
declines in transmission [10,29], perhaps due to the rapidity of
the declines to low levels of transmission in these areas. How-
ever, a recent increase in malaria hospital admissions in
western Kenya could be an example of this phenomenon [30],
and so it remains an open question.
Few studies have quantified the rate of development of
immunity to the different manifestations of severe malaria.
Quantifying these processes is important to allow the prediction
of the likely impact of interventions which are designed to
reduce exposure during early years, including seasonal malaria
chemoprophylaxis (SMC), use of insecticide-treated nets (ITNs)
and vaccination via the Expanded Programme for Immuniz-
ation (EPI), but which may leave older individuals at risk. A
better understanding of the rate at which immunity is acquired
is additionally likely to promote a better understanding of the
pathophysiology of severe malaria.
In 1999, Gupta et al. used a mathematical model fitted to
the age distribution of cerebral and non-cerebral malaria
incidence across different transmission settings in Kenya and
Gambia to estimate the rate of acquisition of immunity to these
syndromes [11,31]. This model assumed that infections were
acquired at a constant rate from birth, but that in young infants
the proportion of cases with severe diseasewas reduced by pas-
sive immunity frommaternal antibodies and that theproportion
of caseswith severe disease variedwith exposure. Their analysis
suggested that immunity to non-cerebral malaria was acquired
after only a few infectious bites. However, in order to repli-
cate the age distribution of non-cerebral malaria, alternative
models were required that explicitly accounted for the exposure
to multiple antigenic types of malaria, and increasing virulence
of later infections [31]. The apparent contradictionbetween these
two analyses—one suggesting rapid acquisition of immunity to
severe disease and the other suggesting increasing case fatality
with increasing age—has yet to be resolved. Indeed, there are
still many unanswered questions about the development of
immunity to severe malaria [2,32].
In an attempt to resolve some of these contradictions, we
estimate the rate of acquisition of immunity to different
forms of severe malaria by extending a published mathemat-
ical model of malaria transmission [33,34] to incorporate the
development of immunity to severe disease. The model is
fitted to data from Tanzania in which cases are stratified
according to the main symptoms of severe disease—severe
malarial anaemia, cerebral malaria and respiratory distress
[4]—as well as to a wider summary analysis of severe disease
patterns across different transmission intensities [5,35].2. Material and methods
(a) Tanzanian study
Full details of the Tanzanian study are published elsewhere [4]
but are summarized briefly here. Data from hospital admissions
for severe malaria from northeastern Tanzania were collected
prospectively from nine hospitals over a period of one year
from February 2002, and from one hospital for a period of six
months from August 2002.The population in this area is culturally and ethnically homo-
geneous, but exposed to highly variable levels of P. falciparum
transmission intensity, which depend on the altitude from sea
level to above 1800 m [36]. Children living in low-lying areas
have much higher admission rates for severe malaria than chil-
dren living in high-altitude villages [4]. In total, data from 1989
people with documented evidence of severe malaria (as defined
in [4]) and known place of residence were included in this study,
of whom 134 (6.7%) had a fatal outcome.
Severe malarial anaemia was defined as P. falciparum parasi-
taemia (of any density) with haemoglobin concentration (Hb)
less than 5 g dl21 (HaemoCue AB, A¨ngelholm, Sweden). Cerebral
malaria was defined as P. falciparum parasitaemia (of any density)
with Blantyre coma score (BCS) less than 4 and, if there was
reduced response to pain, blood glucose level greater than
38 mg dl21 (2.1 mmol l21), no convulsions within 1 h of diagnosis
and no anticonvulsants administered within 6 h of diagnosis.
Malaria with respiratory distress was defined as parasitaemia (of
any density) with lower chest wall inspiratory recession or abnor-
mally deep respiration. Patients who did not meet any of these
criteria but whomet the criteria for inclusion in the study reported
in [4] are classified as ‘other severe malaria’ cases.
Each ward was classified into one of six groups of differing
transmission intensity: below 600 m, 600–1200 m and more
than 1200 m.a.s.l. in each of Kilimanjaro and Tanga regions.
The median journey time to the hospital that patients reported
was also used in the analysis.(b) Other African data
To add information from areas with intermediate transmission,
which were not represented in the Tanzanian study, we also
used data on incidence of severe malaria from nine sites across
Africa collected together by Marsh & Snow [35], together with
data on the age distribution of severe malaria in each of these
sites and the parasite prevalence in 2–10-year-olds reported by
Okiro et al. [5]. In these studies, severe malaria was defined as a
hospitalized case with a positive blood smear for P. falciparum
where no other detectable cause for the clinical presentation
could be identified. Some of the data were summarized in [3], in
which the incidence of acute respiratory infection (ARI) was also
reported using the same method for calculating the denominator
population. The ARI incidence was similar between locations,
suggesting that the calculated denominator was in a similar ratio
to the true catchment population in the different sites.(c) Model structure and estimation of parameters
We used a published transmission model [33], which has recently
been updated by fitting to extensive clinical disease data [34].
The model is described in full in the latter. In brief, the previously
published model incorporates individuals ageing and being con-
tinuously exposed to infection and acquiring immunity. The rate
of acquisition of this immunity depends on the level of exposure,
as measured by the entomological inoculation rate (EIR). There
are three effects of immunity in this previously published model:
(i) a reduction in the probability of initial infection, with the
most marked reductions in teenagers and adults, reflecting pre-
erythrocytic immunity, but with only modest effect; (ii) a gradual
reduction in the probability of developing clinical disease given
infection, representing the development of blood-stage immunity
over repeated exposures; and (iii) a lower parasite density in
asymptomatic infection following repeated exposure, leading to
a reduction in both the probability of detection and in onward
infectiousness to mosquitoes. The model is stratified by age and
by degree of exposure to mosquitoes. The model was validated
by fitting to age-stratified data on the incidence of clinical disease,
PCR positivity and parasite prevalence, and EIR measurements.
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Figure 1. Geographical characteristics of study area, severe disease incidence, population density and travel time to hospital by ward. The study was conducted in
northeastern Tanzania, where (a) the altitude increases from the coast in the southeast to the mountains in the northwest of the study area (altitude of each ward
in metres). There is also geographical variation in (b) the incidence of severe malaria according to admissions to hospital per 1000 head of population, (c) population
density per km2 and (d ) median travel time to the hospital where the case was admitted by ward, in hours, as reported by patients’ families (with the hospitals in
the study marked with yellow diamonds).
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3Here, we extended the model by adding another immunity
function to capture the peak incidence of severe disease at younger
ages than the peak incidence of uncomplicated malaria. As indi-
viduals are repeatedly infected with malaria, they acquire this
immunity, measured by the variable IVA. At birth, individuals
have some level of maternally derived immunity, IVM, which is
also determined by exposure of mothers. Mathematically, this
can be written as the level of this immunity in individuals of age
a in an area with EIR 1, increasing with exposure as
@IVA(a, 1)
@t
þ @IVA(a, 1)
@a
¼ L(a, 1)
L(a, 1)uV þ 1
IVA(a, 1)
dV
,
whereL(a,1) is the force of infection at age a, uV represents a period
during which immunity cannot be boosted following a previous
boost and dV governs the duration of immunity, representing the
assumption that this immunity would decline in the absence
of exposure. Maternal immunity IVM is assumed to be at birth a
proportion PVM of the acquired immunity of a 20-year-old in
the same transmission setting and to decay exponentially with
rate 1/dVM.
The proportion of new infections that develop into severe dis-
ease declines as this level of immunity increases, with a sigmoidal
function given by
u(a, 1) ¼ u0 u1 þ 1 u11þ fV(a)((IVA(a, 1)þ IVM(a, 1))=IV0)kV
 
,
where u0 is the proportion in naive individuals, u0u1 is the pro-
portion in a maximally immune individual, and IV,0 and kV arescale and shape parameters. fV(a) is a purely age-dependent func-
tion that allows the effect of immunity to differ by age, given by
fV(a) ¼ 12(12fV0)/(1þ(a/aV)gv) at age a, with parameters fV0, aV
and gV. Hence the incidence of severe malaria is u(a,1)L(a,1).
The parameters allow for a flexible functional form for the
dependence of the proportion u on either exposure or age. The
other model parameters not related to severe disease were
fixed at the values estimated by Griffin et al. [34].
For each incident case of severemalaria the proportion of severe
cases presenting with any individual symptom (severe anaemia,
cerebral malaria or respiratory distress) was assumed to be age-
dependent. The proportion of severe cases presenting with each
symptom was assumed to be independent of the others and there-
fore any combination of the three symptoms occurs with a
probability given by the product of the individual symptoms.
The proportion of severe malaria cases presenting with each
symptom at age a is
P(symptom) ¼ q0 þ (q1  q0)(1 era),
with a separate set of parameters q0, q1 and r for each symptom.
The case fatality ratio was estimated for each combination of
symptoms, with no age dependence (other than in the pro-
portion of cases presenting with each symptom).
We included a journey-time-dependent probability of cases
arriving in hospital as a number of studies have demonstrated
that longer journey times to hospital are associated with a
lower probability of arrival at a healthcare facility [37–39].
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Figure 2. Age distribution of cases admitted to hospital for severe malaria by setting. The observed incidence of severe malaria by age alongside the model fit. The
first two rows are data from Tanzania in order of increasing parasite prevalence: (a) Kilimanjaro high altitude, (b) Tanga high altitude, (c) Kilimanjaro mid-altitude,
(d) Tanga mid-altitude, (e) Kilimanjaro low altitude and ( f ) Tanga low altitude. The last three rows are data from datasets presented by Okiro et al. [5] and Marsh &
Snow [35], ordered by increasing parasite prevalence: (g) Bakau, Gambia; (h) Kilifi Township, Kenya; (i) Mponda, Malawi; ( j ) Foni Kansala, Gambia; (k) Sukuta,
Gambia; (l ) Kilifi North, Kenya; (m) Siaya, Kenya; (n) Kilifi South, Kenya; and (o) Ifakara, Tanzania. The shaded areas represent the 95% credible intervals of the fit.
These are the raw data, without the scaling for different case definitions and catchment areas in these two groups of studies.
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4The differences in definition of the population at risk in the
Tanzania study compared with the pooled summary studies from
elsewhere in Africa give rise to markedly different scales for the
overall incidence of disease for a similar age profile of disease (i.e.
a similar transmission setting as defined by parasite prevalence),
and we accounted for these differences by introducing scaling
factors (see electronic supplementary material for further details).
Themodelwas fitted to thedata on incidence of different types of
severediseasebyage.TheEIR in each settingwasprimarily informed
by the parasite prevalence in that setting as themodelled relationship
between EIR and parasite prevalence had previously been validated
against a large number of settings [33,34]. Further details of the
model-fitting methodology and the parameter estimates are given
in the electronic supplementary material, text S1.3. Results
People in the Tanzanian study lived at awide range of altitudes,
leading to a high degree of variability inmalaria risk (figure 1a),with hospitals placed in areas of highest population density
(figure 1cd). By far the highest incidence of severe malaria
was seen in the low-altitude area in the southwest, near the
sea, in Tanga (figure 1b). Just under half (47%) of the severe
malaria cases, and 78% of cases who died, presented with at
least one of cerebral malaria, severe malarial anaemia or respir-
atory distress, and 8% of cases were admitted with more than
one of these syndromes. The combination of respiratory distress
and anaemia accounted for 60% of all cases with more than one
syndrome. In the highest transmission area (Tanga, altitude
below 600 m), the majority of admissions were in the youngest
age groups (43% aged below 1 year), the most common mani-
festation was severe malarial anaemia (47% of cases) and 3%
of cases presented with cerebral malaria.
The best-fitting mathematical model captured the differ-
ences in admission patterns by age (figure 2) across the wide
range of settings. As was previously described by Okiro et al.
[5], these data show the age shift in severe malaria from
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Figure 3. Model functions estimated by fitting to the data. (a) Proportion of infections that progress to severe malaria plotted against the number of infections
experienced so far, for three different EIRs. (b) Proportion of cases of severe malaria of a given age that will present with severe anaemia, cerebral malaria,
respiratory distress or none of these symptoms. (c) The case fatality ratio for severe malaria in this cohort depending on the combination of symptoms ( point
estimates, dots; 95% confidence intervals, bars). (d ) Given a case of severe disease, the age-dependent symptoms (b) combined with the symptom-related mortality
(c) can be combined to give a case fatality ratio by age (solid line), which can be compared with the observed data (blue). For (b) and (d ), the lines represent the
best fit and the shaded areas represent the 95% credible intervals. In (b) and (c), ‘other’ refers to those with severe malaria as defined in [4], but without severe
anaemia, cerebral malaria or respiratory distress.
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5younger to older ages as the transmission intensity decreases.
Figure 3a shows the estimated proportion of infections that
develop into severe malaria, plotted against the expected
number of infections experienced so far. Overall, the pro-
portion of infections resulting in severe disease is very low.
In high transmission settings this proportion rises at first
(due to loss of maternal immunity), before gradually falling.
At an EIR of two infectious bites per person per year, the
proportion of infections resulting in severe disease falls more
rapidly, presumably because of age-related gains in immune
system competence (i.e. at low EIRs, children age more
between each infection), but still takes several infections to
fall below 1/10 of the initial proportion. The presentation of
different symptoms was estimated to be modified by age,
with the proportion of cases presenting with severe anaemia
declining from 55% (95% CI: 49–62) at birth to 21% (18–25)
at age 10 years (figure 3b). The proportion of cases presenting
with cerebral malaria increased from 2% (0.5–4) at birth to14% (11–16) by age 10 years. The proportion of cases present-
ing with respiratory distress was approximately constant after
the first year of life at 10%, consistent with previous analyses of
these data, which found that the variable most closely associ-
ated with respiratory distress was travel time to hospital [4].
As expected, among children admitted with severe malaria,
the case fatality ratio increased with the number of syndromes
present and was higher for cases of cerebral malaria than for
cases of severe malarial anaemia (figure 3c). The combination
of age-related symptoms and symptom-related mortality
gives an overall case fatality ratio of the fitted model between
6% and 7%, increasing gradually with age, although there is
some indication that the fitted value underestimates the case
fatality ratio at older ages (figure 3d ). As shown in electronic
supplementary material, figure S3, the assumption that the
occurrence of each symptom depends only on age may not
be valid as there were some differences in symptoms seen
between two areas of differing transmission intensity.
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Figure 4. Changing admission patterns with increasing transmission. Incidence
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6In the fitted mathematical model, the incidence of severe
malaria increases with parasite prevalence, reaching a plateau
when the prevalence in 2–10-year-olds is approximately 50%
(figure 4). A slight decrease in incidence at very high preva-
lence was estimated but the uncertainty means that a
continuing plateau or slight increase cannot be ruled out.
Figure 5 shows themodel-predicted age patterns of parasite
prevalence, incidence of clinicalmalaria and incidence of severe
malaria. As has previously been described [8], the model pre-
dicts a more rapid acquisition of immunity to severe malaria,
followed by development of immunity to clinical malaria and
finally in older children/adults to parasitaemia.4. Discussion
Our analysis demonstrates that variations in patterns of severe
malaria with age and transmission intensity can be explained
by exposure- and age-driven acquisition of immunity, which
determine the incidence of severe malaria, coupled with
age-dependent physiological changes, which determine the
dominant clinical syndrome of severe malaria. In accordance
with previous studies [11,31], our analysis shows an increase
in immunity with cumulative exposure. However, by includ-
ing multiple syndromes and fitting a model across multiple
transmission intensities simultaneously we estimate a more
gradual acquisition of immunity to severe disease than pre-
viously suggested. While the overall risk of severe disease
varies with force of infection, we were able to explain patterns
of severe disease syndromes using a model of a solely physio-
logical, age-dependent process. In particular, the proportion of
the first few infections that lead to severe disease is highly
dependent on the EIR (figure 3a). In a high-transmission set-
ting, the first 30 infections are experienced very rapidly, and
each individual infection has a low probability of progressing
to severe disease episodes as initially infants are protected by
maternal immunity, and then immunity is acquired rapidly.
In a lower-transmission setting (e.g. EIR ¼ 2), infections are
experienced more slowly, and therefore maternal immunityis less important, but age-related gains in immune system com-
petence decrease the proportion of infections that result in
severe malaria. This interaction between acquisition of immu-
nity to severe disease and age is a complex dynamic process,
and our model provides a mechanism for investigating how
disease patterns may change as transmission reduces.
In addition to the dynamics of severe disease overall, we
have modelled the effect of age on symptoms. The proportion
of severe cases presenting with severe malarial anaemia is esti-
mated to decline steadily with age, whereas the proportion of
cases presenting with cerebral malaria increases, and the
proportion of cases presenting with respiratory distress was
estimated to be independent of age. These observations
suggest that the observed variation in severe disease presen-
tation with age across a wide range of transmission settings
may be driven by a combination of variation in the rate of
acquisition of immunity to severe disease per sewith exposure
and a declining proportion of severe cases developing severe
malarial anaemia with age. The increased proportion of
severe cases developing cerebral malaria with increasing age,
although real, is likely to have a smaller effect on the overall
pattern of disease. The balance between acquired immunity
and exposure results in an increasing incidence of severe
malaria with increasing EIR, which appears to tail off slightly
at very high EIR, as suggested by Snow et al. [3]. This combined
modelling approach also allows us to show the shift in the
burden of parasitaemia, clinical disease and severe disease
with age in different transmission settings, as discussed by
Marsh & Kinyanjui [40] and Langhorne et al. [2], showing the
different age shifts in each type of infection (figure 5).
There are, of course, limitations to the use of hospital
admission data for studies of severe illness. First, whether
people with severe malaria come to the hospital at all, and
how severely ill they are when they arrive, will be affected by
access, both spatial and economic, and treatment-seeking be-
haviour [38]. Hospital data may thus not be representative of
patterns of disease in the community, and in particular, may
under-represent disease incidence and presentation in infants
and very young children who are less able to attract attention
to their illness [41,42]. Hospital data may also misrepresent
the true incidence of different disease syndromes. For example,
severe anaemia has a slower and less dramatic presentation
than cerebral malaria, which may be more likely to cause
death before effective treatment can be obtained, and this
may result in biased estimates of relationships with age and
exposure. In addition, the BCS, used to define cerebral malaria,
may underestimate the incidence of this syndrome in infants,
particularly below eight months of age, as they have not yet
fully developed the ability to localize pain [43].
Furthermore, previous or subsequent episodes of mild or
severe disease were not recorded for these cases. Ideally we
would test our model predictions in longitudinal studies
incorporating severe and uncomplicated malaria and
asymptomatic exposure into the model framework. However,
the resulting close monitoring and active case detection
of malaria are likely to result in prompt and effective
treatment of non-severe malaria such that severe malaria
becomes less likely.
It shouldalsobe stressed that themajorityof thesedatacome
froma small numberof siteswithin a small numberof countries.
Studies such as this should be repeated inmany other countries
acrossAfrica before themodel can be reliablyused topredict the
patterns and absolute burden of severe malaria elsewhere.
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Figure 5. Age patterns of disease and infection. Model-predicted age distribution of incidence of severe malaria, clinical malaria and prevalence of parasites as
detected by microscopy, at annual EIRs of (a) 2 and (b) 50. These EIRs correspond to parasite prevalences of 13% and 58%, respectively, in 2–10-year-olds. Each
curve is the probability distribution of one outcome over 0–20-year-olds. (Online version in colour.)
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7Factors that could affect the patterns of severe disease include
nutritional status, socio-economic status, human and parasite
genetics and seasonality. Furthermore, health systems vary
widely across Africa, as does access to ACTs, which will affect
the incidence of severe disease [44].
There are also limitations to this modelling approach. We
have assumed that immunity to severe disease is acquired
as a direct consequence of exposure but do not consider the
biological mechanisms by which this immunity is acquired.
Strain-specific immunity is one mechanism that can reproduce
the observed relationship between age and disease risk
[45–47]. However, antibody- and T-cell-mediated immunity
to conserved antigens that is gradually acquired with exposure
could also reproduce these risk relationships. Moreover, age-
related changes in the predominant mechanisms of immunity
(e.g. the balance between humoral and cellular mechanisms
or between inflammatory and regulatory responses [48]) may
explain the age-dependent changes in the proportions of differ-
ent disease syndromes. Uncovering the biological mechanisms
conferring both susceptibility and resistance to severe disease
will aid future vaccine design as well as improve our under-
standing of the immune correlates of protection.
Given the progressive declines in transmission that have
been observed in many settings in the last decade, it is likely
that both the incidence and pattern of severe disease will con-
tinue to change in the coming years. If transmission continues
to decline, reduced acquisition of immunity in young children
coupled with gradual loss of immunity in older children and
adults will leave a larger proportion of the population suscep-
tible to severe disease. Although the absolute risk of severedisease—at any age—is expected to decline and remain low
as long as transmission continues to decline, a very large at-
risk population will emerge that is highly vulnerable should
malaria transmission start to rise again. This at-risk population
will include a large proportion of older children and adults,
and this analysis suggests that severe disease is likely to present
as cerebral malaria, with an associated high case fatality ratio.
Careful monitoring of the decline in immunity associated with
reduced transmission will therefore be needed to ensure
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